N-(2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-5-YL)-3-HYDROXY-4-(2-(2-NITROPHENYL)DIAZENYL)-2-NAPHTHALENECARBOXAMIDE
UNII JMG6TYX7UG
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-hydroxy-4-(2-(2-nitrophenyl)diazenyl)-2-naphthalenecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JMG6TYX7UG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 38133-90-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H16N6O5 RSJRBKUJZGGVMR-ZQHSETAFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-hydroxy-4-(2-(2-nitrophenyl)diazenyl)-2-naphthalenecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.